The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
Open accessAbstract
Objective: To determine whether risk adapted intraoperative radiotherapy, delivered as a single dose during lumpectomy, can effectively replace postoperative whole breast external beam radiotherapy for early breast cancer. Design: Prospective, open label, randomised controlled clinical trial. Setting: 32 centres in 10 countries in the United Kingdom, Europe, Australia, the United States, and Canada. Participants: 2298 women aged 45 years and older with invasive ductal carcinoma up to 3.5 cm in size, cN0-N1, eligible for breast conservation and randomised before lumpectomy (1:1 ratio, blocks stratified by centre) to either risk adapted targeted intraoperative radiotherapy (TARGIT-IORT) or external beam radiotherapy (EBRT). Interventions: Random allocation was to the EBRT arm, which consisted of a standard daily fractionated course (three to six weeks) of whole breast radiotherapy, or the TARGIT-IORT arm. TARGIT-IORT was given immediately after lumpectomy under the same anaesthetic and was the only radiotherapy for most patients (around 80%). TARGIT-IORT was supplemented by EBRT when postoperative histopathology found unsuspected higher risk factors (around 20% of patients). Main outcome measures: Non-inferiority with a margin of 2.5% for the absolute difference between the five year local recurrence rates of the two arms, and long term survival outcomes. Results: Between 24 March 2000 and 25 June 2012, 1140 patients were randomised to TARGIT-IORT and 1158 to EBRT. TARGIT-IORT was non-inferior to EBRT: the local recurrence risk at five year complete follow-up was 2.11% for TARGIT-IORT compared with 0.95% for EBRT (difference 1.16%, 90% confidence interval 0.32 to 1.99). In the first five years, 13 additional local recurrences were reported (24/1140 v 11/1158) but 14 fewer deaths (42/1140 v 56/1158) for TARGIT-IORT compared with EBRT. With long term follow-up (median 8.6 years, maximum 18.90 years, interquartile range 7.0-10.6) no statistically significant difference was found for local recurrence-free survival (hazard ratio 1.13, 95% confidence interval 0.91 to 1.41, P=0.28), mastectomy-free survival (0.96, 0.78 to 1.19, P=0.74), distant disease-free survival (0.88, 0.69 to 1.12, P=0.30), overall survival (0.82, 0.63 to 1.05, P=0.13), and breast cancer mortality (1.12, 0.78 to 1.60, P=0.54). Mortality from other causes was significantly lower (0.59, 0.40 to 0.86, P=0.005). Conclusion: For patients with early breast cancer who met our trial selection criteria, risk adapted immediate single dose TARGIT-IORT during lumpectomy was an effective alternative to EBRT, with comparable long term efficacy for cancer control and lower non-breast cancer mortality. TARGIT-IORT should be discussed with eligible patients when breast conserving surgery is planned. Trial registration: ISRCTN34086741, NCT00983684.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Hudis, C. A., Barlow, W. E., Costantino, J. P., Gray, R. J., Pritchard, K. I., Chapman, J.-A. W., Sparano, J. A., Hunsberger, S., Enos, R. A., Gelber, R. D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3523 · Cited by 864
Vaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D. J., Keshtgar, M., Flyger, H. L., Massarut, S., Alvarado, M., Saunders, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61950-9 · Cited by 831
Self-citationTaylor, C., Correa, C., Duane, F. K., Aznar, M. C., Anderson, S. J., Bergh, J., Dodwell, D., Ewertz, M., Gray, R., Jagsi, R., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.72.0722 · Cited by 785
Vaidya, J. S., Joseph, D. J., Tobias, J. S., Bulsara, M., Wenz, F., Saunders, C., Alvarado, M., Flyger, H. L., Massarut, S., Eiermann, W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60837-9 · Cited by 772
Self-citationVeronesi, U., Orecchia, R., Maisonneuve, P., Viale, G., Rotmensz, N., Sangalli, C., Luini, A., Veronesi, P., Galimberti, V., Zurrida, S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70497-2 · Cited by 767
Strnad, V., Ott, O. J., Hildebrandt, G., Kauer-Dorner, D., Knauerhase, H., Major, T., Lyczek, J., Guinot, J. L., Dunst, J., Miguelez, C. G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00471-7 · Cited by 659
Coles, C. E., Griffin, C. L., Kirby, A. M., Titley, J., Agrawal, R. K., Alhasso, A., Bhattacharya, I. S., Brunt, A. M., Ciurlionis, L., Chan, C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31145-5 · Cited by 611
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
Pocock, S. J., Clayton, T. C., & Altman, D. G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08594-x · Cited by 513
Vicini, F. A., Cecchini, R. S., White, J. R., Arthur, D. W., Julian, T. B., Rabinovitch, R. A., Kuske, R. R., Ganz, P. A., Parda, D. S., Scheier, M. F., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32514-0 · Cited by 480
Livi, L., Meattini, I., Marrazzo, L., Simontacchi, G., Pallotta, S., Saieva, C., Paiar, F., Scotti, V., De Luca Cardillo, C., Bastiani, P., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.013 · Cited by 460
Whelan, T. J., Julian, J. A., Berrang, T. S., Kim, D.-H., Germain, I., Nichol, A. M., Akra, M., Lavertu, S., Germain, F., Fyles, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32515-2 · Cited by 427
Travel Distance to Radiation Therapy and Receipt of Radiotherapy Following Breast-Conserving Surgery
Athas, W. F., Adams-Cameron, M., Hunt, W. C., Amir-Fazli, A., & Key, C. R. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.269 · Cited by 422
Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W., Hu, F. B., & Giovannucci, E. L. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv088 · Cited by 395
Polgár, C., Fodor, J., Major, T., Sulyok, Z., & Kásler, M. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.05.008 · Cited by 358
Multicentricity of breast cancer: whole-organ analysis and clinical implications
Vaidya, J., Vyas, J., Chinoy, R., Merchant, N., Sharma, O., & Mittra, I. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.442 · Cited by 294
Self-citationSmits, P. C., Hofma, S., Togni, M., Vázquez, N., Valdés, M., Voudris, V., Slagboom, T., Goy, J.-J., Vuillomenet, A., Serra, A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61852-2 · Cited by 293
Earl, H. M., Hiller, L., Vallier, A.-L., Loi, S., McAdam, K., Hughes-Davies, L., Harnett, A. N., Ah-See, M.-L., Simcock, R., Rea, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30650-6 · Cited by 286
Self-citationGourgou-Bourgade, S., Cameron, D., Poortmans, P., Asselain, B., Azria, D., Cardoso, F., A'Hern, R., Bliss, J., Bogaerts, J., Bonnefoi, H., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv106 · Cited by 234
Belletti, B., Vaidya, J. S., D'Andrea, S., Entschladen, F., Roncadin, M., Lovat, F., Berton, S., Perin, T., Candiani, E., Reccanello, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4453 · Cited by 234
Self-citationVaidya, J. S., Baum, M., Tobias, J. S., D’Souza, D. P., Naidu, S. V., Morgan, S., Metaxas, M., Harte, K. J., Sliski, A. P., & Thomson, E. (2001) · Annals of Oncology · doi:10.1023/a:1011609401132 · Cited by 225
Self-citationGrantzau, T., & Overgaard, J. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.10.004 · Cited by 207
A mathematical model of breast cancer development, local treatment and recurrence
Enderling, H., Chaplain, M. A. J., Anderson, A. R. A., & Vaidya, J. S. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.12.010 · Cited by 203
Self-citationVaidya, J. S., Baum, M. S., Tobias, J. S., et al. (2002) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1275 · Cited by 131
Self-citationMethods for Equivalence and Noninferiority Testing
da Silva, G. T., Logan, B. R., & Klein, J. P. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2008.10.004 · Cited by 118
Herskind, C., Steil, V., Kraus-Tiefenbacher, U., et al. (2005) · Radiation Research · doi:10.1667/rr3292 · Cited by 106
Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results
Burt, L., Ying, J., Poppe, M. M., Suneja, G., & Gaffney, D. K. (2017) · The Breast · doi:10.1016/j.breast.2017.07.004 · Cited by 97
Vaidya, J. S., Bulsara, M. K., Wenz, F. K., Coombs, N. J., Singer, J., Ebbs, S. R., Massarut, S., Saunders, C. M., Douek, M., Williams, N. R., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.05.008 · Cited by 92
Self-citationWelzel, G., Boch, A., Sperk, E., Hofmann, F., Kraus-Tiefenbacher, U., Gerhardt, A., Sütterlin, M., & Wenz, F. K. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-9 · Cited by 88
Self-citationEffect of Travel Distance and Time to Radiotherapy on Likelihood of Receiving Mastectomy
Goyal, S., Chandwani, S., Haffty, B. G., & Demissie, K. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4093-8 · Cited by 82
Corica, T., Nowak, A. K., Saunders, C. M., Bulsara, M. K., Taylor, M., Vaidya, J. S., Baum, M., & Joseph, D. J. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.04.024 · Cited by 80
Self-citationPartial breast irradiation for early breast cancer
Hickey, B. E., Lehman, M., Francis, D. P., & See, A. M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007077.pub3 · Cited by 72
Keshtgar, M., Williams, N. R., Bulsara, M. K., Saunders, C. M., Flyger, H., Cardoso, J. S., Corica, T., Bentzon, N., Michalopoulos, N. V., & Joseph, D. J. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2641-8 · Cited by 67
Self-citationSegatto, I., Berton, S., Sonego, M., Massarut, S., Perin, T., Piccoli, E., Colombatti, A., Vecchione, A. M., Baldassarre, G., & Belletti, B. (2014) · Oncotarget · doi:10.18632/oncotarget.2195 · Cited by 67
Self-citationVaidya, J. S., Wenz, F. K., Bulsara, M. K., Tobias, J. S., Joseph, D. J., Saunders, C. M., Brew‐Graves, C., Potyka, I., Stephen Morris, A., Vaidya, H. J., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20730 · Cited by 66
Self-citationRadiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway
Fabris, L., Berton, S., Citron, F., D’Andrea, S., Segatto, I., Nicoloso, M. S., Massarut, S., Armenia, J., Zafarana, G., Rossi, S., et al. (2016) · Oncogene · doi:10.1038/onc.2016.23 · Cited by 63
Self-citationAlvarado, M. D., Conolly, J., Park, C., Sakata, T., Mohan, A. J., Harrison, B. L., Hayes, M., Esserman, L. J., & Ozanne, E. M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2782-9 · Cited by 57
Self-citationMulticentricity and recurrence of breast cancer
Baum, M., Vaidya, J. S., & Mittra, I. (1997) · The Lancet · doi:10.1016/s0140-6736(05)60950-6 · Cited by 46
Self-citationVaidya, A., Vaidya, P., Both, B., Brew‐Graves, C., Bulsara, M. K., & Vaidya, J. S. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014944 · Cited by 42
Self-citationAndersen, K. G., Gärtner, R., Kroman, N. T., Flyger, H. L., & Kehlet, H. (2011) · The Breast · doi:10.1016/j.breast.2011.07.011 · Cited by 41
Self-citationAziz, M. H., Schneider, D., Clausen, S., Sperk, E., Herskind, C., Afzal, M., & Wenz, F. K. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-174 · Cited by 41
Self-citationp70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation
Segatto, I., Berton, S., Sonego, M., Massarut, S., Fabris, L., Armenia, J., Mileto, M., Colombatti, A., Vecchione, A. M., Baldassarre, G., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.006 · Cited by 34
Self-citationBeckett, H., & Radford, J. (2016) · PubMed · Cited by 32
Targeted radiotherapy for early breast cancer
Vaidya, J. S., Bulsara, M. K., Wenz, F. K., Tobias, J. S., Joseph, D. J., & Baum, M. S. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33316-0 · Cited by 17
Self-citationDirbas, F. M., Jeffrey, S. S., & Goffinet, D. R. (2004) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2004.19.673 · Cited by 16
A novel approach for local treatment of early breast cancer.
Vaidya, J. S. (2002) · Europe PMC (PubMed Central) · Cited by 15
Self-citation
Metadata
- Authors
- Vaidya, J. S., Bulsara, M., Baum, M., Wenz, F., Massarut, S., Pigorsch, S., Alvarado, M., Douek, M., Saunders, C., Flyger, H. L., Eiermann, W., Brew-Graves, C., Williams, N. R., Potyka, I., Roberts, N., Bernstein, M., Brown, D., Sperk, E., Laws, S., Sütterlin, M., Corica, T., Lundgren, S., Holmes, D., Vinante, L., Bozza, F., Pazos, M., Le Blanc-Onfroy, M., Gruber, G., Polkowski, W., Dedes, K. J., Niewald, M., Blohmer, J., McCready, D., Hoefer, R., Kelemen, P., Petralia, G., Falzon, M., Joseph, D. J., & Tobias, J. S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2020-08-19
- Volume
- 370
- Pages
- m2836
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3067502370
- Cited by
- 293
- References
- 49
- FWCI
- 13.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.